Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Study identification

NCT ID

NCT05174169

Recruitment status

Recruiting

Study type

Interventional

Phase

Phase 2, Phase 3

Lead sponsor

NRG Oncology

Other

Enrollment

1,912 participants

Conditions and interventions

Eligibility (public fields only)

Age range

18 Years and older

Sex

All

Healthy volunteers

Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date

Jul 7, 2022

Primary completion

Mar 9, 2029

Completion

Mar 9, 2030

Last update posted

May 5, 2026

2022 – 2030

United States locations

U.S. sites

1016

U.S. states

49

U.S. cities

709

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.